Claudine Isaacs, MD
Disclosures: Paid consultant-Pfizer, Inc.-|Paid consultant-AstraZeneca-|Paid consultant-Seattle Genetics-|Paid consultant-PUMA-|Paid consultant-Genentech, Inc.-|Paid consultant-Novartis AG-|Grant or research support-GlaxoSmithKline- - 05/16/2021

 

Dr. Claudine Isaacs is a Professor of Medicine and Oncology, Associate Director for Clinical Research and Leader of the Clinical Breast Cancer Program at the Lombardi Comprehensive Cancer Center (LCCC) at Georgetown University.  She is also the Medical Director of the Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research. She has extensive experience in the conduct of clinical trials focusing on all aspects of breast cancer and currently serves as Co-Chair Endocrine Resistance Working Group of the Translational Breast Cancer Research Consortium (TBCRC) and as Co-Chair of the Clinical Trials Operations Working Group for the I-SPY 2 Trial. She has authored over 200 peer-reviewed publications and edited two textbooks. She has served on a number of national committees including the Scientific Program Committees at ASCO, the ASCO Breast Cancer Guideline Advisory Group, the Breast Oncology Local Diseases Task Force of the Breast Steering Committee of the NCI